EnglishThe shareholders of Ropharma Braşov, a company specializing in the distribution of drugs, have approved the transfer of the stock from the Rasdaq market to the 1st tier of the Bucharest Stock Exchange. Another decision which was approved includes the increase of the share capital by 16.44 million lei, from 12.6 million lei to 29.1 million lei.
The funds for the share capital increase will come from the statutory reserves, by issuing 164.48 million shares with a face value of 0.1 lei, at a ratio of 1.3 new shares for each share held on the registration date.
The company"s investors have also approved the increase of a line of credit taken from ING Bank up to 15 million Euros.
Ropharma is indirectly controlled by businessman Mihai Miron. The companies ADD Pharmaceuticals and Rimia Investments, registered in Cyprus, hold 23.4%, and 26.6% of the shares, respectively. Another shareholder of the company is Arrow Pharmaceuticals, a company registered in the United States, which holds 31.31% of the company, whereas the Authority For State Assets Recovery (AVAS) holds 0.33%.
Euro
Dolar SUA
Franc elveţian
Liră sterlină
Gram de aur
